English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People

 
• By Neena Brizmohun
  
Pfizer biohaven migraine deal
Aquipta is an oral, once-daily treatment for migraine • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image

More from United Kingdom

More from Europe